NEW-YORK CITY – 12.17.2024. Archeon Medical is thrilled to announce the establishment of a subsidiary in the United States. This strategic move reinforces its commitment to the North American market. This will enable enhanced support for a growing customer base and accelerate the adoption of its life-saving technologies.
TRANSFORMING CARE WITH EOLIFE
Building on the remarkable success of its groundbreaking ventilation feedback device, EOlife, in the United States—which accounts for 60% of its total revenue in 2024—Archeon Medical establishes a local presence in this key market. Furthermore, EOlife has revolutionized the field of manual ventilation by offering a more efficient and personalized approach to patient care. In addition, by providing accurate, real-time measurements of delivered tidal volume, EOlife has transformed cardiopulmonary resuscitation (CPR), setting a new standard for airway management.
“The United States is a pivotal market for Archeon Medical. We are poised to accelerate the adoption of our innovative solutions and further improve patient care. EOlife has already made a significant impact on patient care in the US. With our expanded presence through, we aim to build on this success and continue to revolutionize the field of manual ventilation.”
Valentine Oqda, Head of US operations at Archeon Medical.
TRUSTED BY LEADING HEALTHCARE INSTITUTIONS
FDA-approved in 2023, EOlife has already gained the trust of several major healthcare players in the United-States. Including: John Hopkins EMS Services (Howard County), Palo Alto Fire Department, Stanford’s Children Hospital, Palo Alto, CA, Rush University Hospital, IL etc. This endorsement has strengthened Archeon medical’s conviction in expanding its market presence.
A COMMITMENT TO EXCELLENCE
By establishing a local subsidiary in the United States, Archeon Medical solidifies its position as a leader in innovative ventilation solutions. Moreover, this aligns with its commitment to supporting educational initiative, such as the Manual Ventilation Academy led by Bob Page. Additionally, through program like the Difficult Airway Course. It empowers healthcare professionals with skills and knowledge to deliver exceptional care and improve patient outcomes.
About Archeon Medical
Founded in 2018, by Alban De Luca and Pierre-Edouard Saillard, Archeon Medical is a pioneer in emergency medical technology. Archeon Medical developed EOlife, the ventilation feedback device has transformed the way healthcare providers approach manual ventilation. By providing real-time feedback and ensuring adherence to guidelines, EOlife empowers medical teams to deliver life-saving care to patients in critical condition. With a global footprint and a commitment to innovation, Archeon is dedicated to improving patient outcomes worldwide.